MeSH term
Frequency | Condition_Probility | Animals | 41 | 0.0 |
CHO Cells | 3 | 0.0 |
Cloning, Molecular | 12 | 0.0 |
Cytotoxicity, Immunologic/immunology | 3 | 4.0 |
DNA Primers | 4 | 0.0 |
Endothelium, Vascular/*immunology | 2 | 2.0 |
Female | 25 | 0.0 |
Flow Cytometry | 8 | 0.0 |
HLA Antigens/*genetics | 26 | 3.0 |
Hamsters | 4 | 0.0 |
Histocompatibility Antigens Class I/*genetics | 22 | 6.0 |
Humans | 112 | 0.0 |
Killer Cells, Natural/*immunology | 18 | 3.0 |
Polymerase Chain Reaction | 8 | 0.0 |
Recombinant Proteins/immunology | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 80 | 0.0 |
Swine | 2 | 0.0 |
Transfection | 23 | 0.0 |
beta 2-Microglobulin/genetics | 2 | 9.0 |
English Abstract | 4 | 0.0 |
Gene Expression Regulation | 7 | 0.0 |
Genes, MHC Class I/*immunology | 3 | 13.0 |
Histocompatibility Antigens Class I/genetics | 5 | 5.0 |
*Membrane Proteins | 2 | 0.0 |
Mutation | 3 | 0.0 |
Cells, Cultured | 10 | 0.0 |
Gene Expression | 3 | 0.0 |
HLA Antigens/genetics/*immunology | 5 | 6.0 |
Histocompatibility Antigens Class I/genetics/*immunology | 4 | 14.0 |
Interferon Type II/biosynthesis | 2 | 0.0 |
K562 Cells | 6 | 1.0 |
Pregnancy | 14 | 0.0 |
Pregnancy Trimester, First | 4 | 1.0 |
Alleles | 12 | 0.0 |
DNA/genetics | 3 | 0.0 |
Gene Frequency | 3 | 0.0 |
HLA-A Antigens/genetics | 4 | 2.0 |
HLA-B Antigens/genetics | 3 | 1.0 |
Polymorphism, Genetic | 6 | 0.0 |
Antibody Specificity | 4 | 0.0 |
Cell Communication | 2 | 0.0 |
Immunity, Cellular | 3 | 0.0 |
Cytotoxicity, Immunologic | 8 | 0.0 |
HLA Antigens/*physiology | 2 | 14.0 |
Histocompatibility Antigens Class I/*physiology | 5 | 23.0 |
T-Lymphocytes, Cytotoxic/*immunology | 3 | 0.0 |
beta 2-Microglobulin/physiology | 2 | 33.0 |
Amino Acid Sequence | 24 | 0.0 |
Cell Line | 25 | 0.0 |
HLA-A Antigens/metabolism | 2 | 15.0 |
Molecular Sequence Data | 37 | 0.0 |
Protein Binding/immunology | 6 | 3.0 |
Protein Processing, Post-Translational/immunology | 2 | 16.0 |
Cytotoxicity Tests, Immunologic | 5 | 1.0 |
*Cytotoxicity, Immunologic | 5 | 1.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
*Lectins, C-Type | 9 | 5.0 |
CD4-Positive T-Lymphocytes/immunology | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 26 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Binding Sites | 6 | 0.0 |
Peptide Library | 2 | 1.0 |
Protein Binding | 8 | 0.0 |
Protein Folding | 3 | 0.0 |
Base Sequence | 26 | 0.0 |
Cell Line, Transformed | 5 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
*Genes, MHC Class I | 16 | 6.0 |
Species Specificity | 4 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
*Antigen Presentation | 3 | 1.0 |
HLA Antigens/genetics/immunology/*physiology | 2 | 100.0 |
Histocompatibility Antigens Class I/genetics/immunology/*physiology | 2 | 100.0 |
Immunity, Natural | 2 | 0.0 |
Placenta/immunology | 3 | 12.0 |
T-Lymphocytes/immunology | 2 | 0.0 |
Down-Regulation | 4 | 0.0 |
Escherichia coli | 2 | 0.0 |
Histocompatibility Antigens Class I/*metabolism | 4 | 4.0 |
Abortion, Habitual/*genetics/immunology | 2 | 40.0 |
Adult | 3 | 0.0 |
Genotype | 3 | 0.0 |
Histocompatibility Testing | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Male | 9 | 0.0 |
*Polymorphism, Genetic | 7 | 0.0 |
Antigens, CD/immunology | 2 | 0.0 |
Comparative Study | 10 | 0.0 |
Dimerization | 3 | 0.0 |
Hydrogen Bonding | 2 | 1.0 |
Macromolecular Substances | 4 | 0.0 |
Models, Molecular | 5 | 0.0 |
Multigene Family | 4 | 0.0 |
Peptide Fragments/immunology/metabolism | 3 | 6.0 |
Protein Conformation | 6 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
*Alleles | 2 | 0.0 |
DNA/*genetics | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
HLA Antigens/*genetics/metabolism | 3 | 25.0 |
Histocompatibility Antigens Class I/*genetics/metabolism | 4 | 21.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Antigens, CD/*immunology | 3 | 0.0 |
Lectins, C-Type/*immunology | 2 | 33.0 |
Receptors, Immunologic/*immunology | 2 | 1.0 |
Antigens, CD/*metabolism | 6 | 0.0 |
HLA Antigens/genetics/*metabolism | 5 | 41.0 |
Histocompatibility Antigens Class I/genetics/*metabolism | 5 | 17.0 |
Killer Cells, Natural/immunology/*metabolism | 3 | 10.0 |
Ligands | 9 | 0.0 |
Membrane Glycoproteins/*metabolism | 4 | 0.0 |
Receptors, Immunologic/*metabolism | 4 | 2.0 |
Crystallography | 2 | 6.0 |
Neoplasms/*immunology | 2 | 1.0 |
Receptors, Immunologic/immunology | 2 | 1.0 |
HLA Antigens/genetics | 6 | 1.0 |
Phylogeny | 2 | 0.0 |
Antibodies, Monoclonal/metabolism | 2 | 0.0 |
HLA Antigens/*metabolism | 3 | 9.0 |
Peptides/immunology | 3 | 2.0 |
Adolescent | 2 | 0.0 |
Child | 2 | 0.0 |
Cell Membrane/immunology | 3 | 1.0 |
Conserved Sequence | 2 | 0.0 |
Receptors, Immunologic/metabolism | 3 | 1.0 |
Cell Membrane/immunology/metabolism | 3 | 2.0 |
Liver/*immunology | 2 | 5.0 |
Mice | 26 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Mice, Inbred NOD | 2 | 0.0 |
Rats | 3 | 0.0 |
Solubility | 4 | 0.0 |
*Gene Expression Regulation | 4 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 3 | 0.0 |
H-2 Antigens/immunology | 2 | 9.0 |
Mice, Transgenic | 2 | 0.0 |
HLA Antigens/*immunology | 4 | 1.0 |
Histocompatibility Antigens Class I/*immunology | 5 | 4.0 |
Computer Simulation | 2 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Nucleic Acid Conformation | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Cytotoxicity, Immunologic/genetics | 2 | 11.0 |
HLA Antigens/*biosynthesis/*genetics/immunology | 2 | 100.0 |
Histocompatibility Antigens Class I/*biosynthesis/*genetics/immunology | 2 | 100.0 |
T-Lymphocytes, Cytotoxic/immunology | 2 | 0.0 |
HLA Antigens/*biosynthesis | 2 | 10.0 |
Histocompatibility Antigens Class I/*biosynthesis | 2 | 5.0 |
Surface Properties | 2 | 1.0 |
Gene Expression Regulation/immunology | 3 | 1.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Antibodies, Monoclonal | 4 | 0.0 |
Genes, MHC Class I/*genetics | 4 | 5.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Histocompatibility Antigens Class I/*chemistry/genetics | 2 | 66.0 |
*Chromosomes, Human, Pair 6 | 3 | 1.0 |
Genes, MHC Class I | 4 | 3.0 |
Isoelectric Focusing | 2 | 0.0 |
Precipitin Tests | 5 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
*Protein Conformation | 2 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
Electrophoresis, Gel, Pulsed-Field | 3 | 1.0 |
Evolution | 3 | 0.0 |
Antigens, CD/metabolism | 2 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
HLA Antigens/*analysis/genetics | 2 | 2.0 |
Antigens, CD/*physiology | 2 | 0.0 |
Membrane Glycoproteins/*physiology | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Protein Sorting Signals/*metabolism | 2 | 16.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
beta 2-Microglobulin/metabolism | 2 | 2.0 |
Blotting, Northern | 5 | 0.0 |
Middle Aged | 3 | 0.0 |
Exons | 3 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Methylation | 4 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
*Gene Expression | 2 | 0.0 |
HLA Antigens/*genetics/immunology | 2 | 4.0 |
Histocompatibility Antigens Class I/*genetics/immunology | 3 | 11.0 |
Blotting, Southern | 3 | 0.0 |
Chromosomes, Human, Pair 6 | 3 | 1.0 |
Genome, Human | 2 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Gene Library | 3 | 0.0 |
Pseudogenes | 3 | 1.0 |
Restriction Mapping | 5 | 0.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
*Major Histocompatibility Complex | 5 | 1.0 |
Genes, Structural | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
DNA/analysis | 2 | 0.0 |
Killer Cells, Natural/immunology | 3 | 0.0 |
Interferon Type II/pharmacology | 2 | 0.0 |
HLA-A Antigens/*genetics | 2 | 1.0 |
Linkage (Genetics) | 2 | 0.0 |
Organ Specificity | 2 | 0.0 |
RNA-Binding Proteins/*physiology | 2 | 10.0 |
Viral Proteins/*physiology | 2 | 6.0 |
HLA Antigens/metabolism | 2 | 6.0 |
Histocompatibility Antigens Class I/metabolism | 2 | 3.0 |
Monocytes/immunology | 2 | 0.0 |
